Domains - items | Meeting 1 | Meeting 2 | Meeting 3 | Meeting 4 | Final rank* |
---|---|---|---|---|---|
10 participants | 7 participants | 7 participants | 7 participants | ||
Pharmacology | |||||
Prescribe the doses and durations following the indication | - | 5 | 8 | 2 | 3 |
Know where to find validated information for medication prescription | 12 | 13 | 10 | 5 | 6 |
Identify adverse drug reactions | - | 8 | 11 | 10 | 10 |
Be critical with new medications | 3 | 4 | - | 17 | 12 |
Identify potential drug interactions | 5 | 3 | 8 | 12 | 12 |
Prescribe in international nonproprietary names | 6 | 22 | - | 6 | 24 |
Prescribe in compliance to marketing authorizations | 19 | 19 | - | 6 | 25 |
Regulatory standards | |||||
Write a legible and understandable prescription for the patient and the one who administers the medication | - | 1 | 1 | 2 | 1 |
Use two-part prescription forms for patients with chronic condition falling under Affections de Longue Durée† | 18 | 5 | 8 | 3 | 10 |
Abide by the terms of use for specific prescriptions: secured forms, special-status medication‡ , restricted prescription, unreimbursed prescription | 21 | 5 | 6 | 3 | 23 |
Include mandatory information of the prescription: identification of prescriber, date, patient’s name, age, weight (for children) | 3 | 17 | 1 | - | 26 |
Know the costs associated with medication prescription: reimbursement rate and patient’s contribution | 23 | 20 | 21 | - | 29 |
Therapeutics | |||||
Identify specific populations (paediatric, pregnant, breastfeeding, elderly, renal impaired) | 8 | - | 1 | 1 | 2 |
Regularly re-evaluate chronic medication prescriptions | 6 | 4 | 19 | 13 | 9 |
Prescribe non-pharmacological treatment (lifestyle habits, dietary changes, physical activity, reassuring advices) over medication | 1 | - | 18 | 19 | 15 |
Deprescribe | 11 | 10 | 19 | - | 18 |
Abstain from systematic medication prescription | 1 | 2 | 17 | - | 19 |
Unifies prescription from different sources | 7 | 10 | 7 | - | 20 |
Use medication prescription software | 22 | 21 | 13 | 20 | 28 |
Communication | |||||
With patient | |||||
Explain a lack of medication prescription to the patient | 8 | 13 | - | 18 | 3 |
Decline inappropriate medication request for prescription medication | 16 | - | 20 | 16 | 5 |
Explain to the patient his/her medication prescription | 8 | 12 | 5 | 8 | 7 |
Assess patient’s adherence | 13 | 13 | 16 | - | 12 |
Identify barriers to medication use | - | 13 | 4 | - | 16 |
Assess self-medication | 16 | 8 | 14 | 15 | 21 |
Explain potential adverse drug reactions to the patient | - | 18 | 14 | 9 | 22 |
With health professionals | |||||
Being critical about the information supplied by the pharmaceutical industry | 15 | - | 22 | 11 | 8 |
Prescribe in collaboration with other health professionals: physicians, pharmacists, pharmacovigilance centres, Health Insurance System representatives, nurses, midwives | 13 | 23 | 23 | 13 | 16 |
Report adverse drug events to Pharmacovigilance Centre | 20 | - | 12 | 20 | 27 |